Spyre Therapeutics Outlines Autoimmune Treatment Strategy at Citi Summit

Biopharmaceutical company Spyre Therapeutics presented its clinical pipeline and investment thesis at the Citi summit, focusing on innovative combination therapies for autoimmune diseases.